Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elisa Bianchi is active.

Publication


Featured researches published by Elisa Bianchi.


Epilepsia | 2016

The semiology of psychogenic nonepileptic seizures revisited: Can video alone predict the diagnosis? Preliminary data from a prospective feasibility study

Giuseppe Erba; Giorgia Giussani; Adam Juersivich; Adriana Magaudda; Valentina Chiesa; Angela Laganà; Gabriella Di Rosa; Elisa Bianchi; John T. Langfitt; Ettore Beghi

To investigate if, when, and to what extent visual information contained in a video‐recorded event allows experienced epileptologists to predict the diagnosis of psychogenic nonepileptic seizures (PNES) without the aid of electroencephalography (EEG).


Epilepsy & Behavior | 2016

A population-based study of active and drug-resistant epilepsies in Northern Italy

Giorgia Giussani; Valentina Canelli; Elisa Bianchi; Carlotta Franchi; Alessandro Nobili; Giuseppe Erba; Ettore Beghi

Drug-resistant epilepsy (DRE) is defined by the International League Against Epilepsy as a failure of adequate trials of two tolerated, appropriately chosen, and used antiepileptic drugs to achieve sustained seizure freedom. Our aim was to calculate the following: (1) the prevalence of active epilepsy and DRE in a well-defined population of Northern Italy and (2) the proportion of incident cases developing DRE. The study population (146,506; year 2008) resided in the province of Lecco, Northern Italy. The medical records of 123 general practitioners were reviewed to identify patients with epilepsy, diagnosed by a neurologist during the period 2000-2008. The point prevalence of active epilepsy and DRE was calculated on December 31, 2008. A total of 747 prevalent patients with epilepsy, 684 patients with active epilepsy, and 342 incident cases were identified. The frequency of DRE was 15.6% (107/684) of all active epilepsies and 10.5% (36/342) of incident cases. The point prevalence was 0.73 per 1000. The standardized prevalence of DRE was 0.7 per 1000 (Italian population) and 0.8 per 1000 (world population). Our data indicate that 1/6 patients with active epilepsy in the general population has DRE, and 1/10 patients with newly diagnosed epilepsy will develop DRE within nine years from the diagnosis.


Journal of Alzheimer's Disease | 2017

Adult-Onset Epilepsy in Presymptomatic Alzheimer’s Disease: A Retrospective Study

Jacopo C. DiFrancesco; Lucio Tremolizzo; Valeria Polonia; Giorgia Giussani; Elisa Bianchi; Carlotta Franchi; Alessandro Nobili; Ildebrando Appollonio; Ettore Beghi; Carlo Ferrarese

BACKGROUND The prevalence of epilepsy with onset in adulthood increases with age, mainly due to the accumulation of brain damage. However, a significant proportion of patients experience seizures of unknown cause. Alzheimers disease (AD) is associated with an increased risk of seizures. Seizure activity is interpreted as a secondary event related to hyperexcitability caused by amyloid-β aggregation. OBJECTIVE Since neurodegenerative processes begin several years before clinical symptoms, epilepsy could be more frequent in the presymptomatic stages of dementia. METHODS We retrospectively reviewed the prevalence of epilepsy of unknown origin with adult onset before cognitive decline in a large cohort of AD patients (EPS-AD) recruited based on clinical and neuropsychological data. Data of patients with epilepsy followed by AD were compared with two control groups: patients with AD without seizures (no EPS-AD) and a large reference population (RP). RESULTS In AD patients, the prevalence of epilepsy of unknown origin, with onset in the adulthood before cognitive decline is 17.1 times higher compared with the RP (95% CI: 10.3-28.3). In EPS-AD, seizures begin on average 4.6 years (median 2.0) before the onset of cognitive symptoms and cognitive decline starts 3.6 years earlier compared with noEPS-AD. CONCLUSIONS Neurodegenerative processes of dementia could play a key role in the pathogenesis of epilepsy in a subgroup of individuals intended to develop cognitive decline. Adult-onset epilepsy of undefined cause could thus represent a risk factor for the ongoing neurodegenerative damage, even preceding by years the onset of clinical symptoms of dementia.


Acta Neurologica Scandinavica | 2015

Clinical and stabilometric measures predicting falls in Parkinson disease/parkinsonisms

E. Gervasoni; D. Cattaneo; P. Messina; E. Casati; A. Montesano; Elisa Bianchi; E. Beghi

Clinical predictors of falls in patients with Parkinson disease (PD) are fairly inaccurate. Stabilometric measures appear useful in investigating the relationship between balance, sensory disturbance, and falls. The aim of the study was to identify the best combination of clinical and stabilometric tests to predict falls prospectively.


Epilepsia | 2017

Antiepileptic drug discontinuation by people with epilepsy in the general population

Giorgia Giussani; Elisa Bianchi; Valentina Canelli; Giuseppe Erba; Carlotta Franchi; Alessandro Nobili; Josemir W. Sander; Ettore Beghi

Rate, reasons, and predictors of antiepileptic drug (AED) discontinuation were investigated in a well‐defined cohort of people with epilepsy to verify efficacy and tolerability of treatment up to 20 years from treatment initiation.


Amyotrophic Lateral Sclerosis | 2015

Extrapyramidal and cognitive signs in amyotrophic lateral sclerosis: A population based cross-sectional study.

Elisabetta Pupillo; Elisa Bianchi; Paolo Messina; Luca Chiveri; Christian Lunetta; Massimo Corbo; Massimiliano Filosto; Lorenzo Lorusso; Benoît Marin; Jessica Mandrioli; Nilo Riva; Francesco Sasanelli; Lucio Tremolizzo; Ettore Beghi

Our objective was to assess the association between amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases such as Alzheimers disease (AD), frontotemporal dementia (FTD) and Parkinsons disease (PD). From May 2007 through August 2012 we investigated 146 patients with newly diagnosed ALS and 146 age- and gender-matched controls. Each individual was screened for cardinal extrapyramidal signs (neurological examination) and cognitive dysfunction (Mini Mental State Examination, MMSE and Frontal Assessment Battery, FAB). Results demonstrated that rigidity was present in 8.2% of cases and 2.1% of controls (adjusted odds ratio, adjOR 5.7; 95% CI 1.5–22.0). The corresponding percentages for bradykinesia and postural instability were, respectively, 8.2 vs. 2.7% (adjOR 4.8; 95% CI 1.4–16.5) and 2.7 vs. 9.6% (adjOR 0.3; 95% CI 0.1–0.9). FAB ≤ 13.4 was recorded in 24.8 vs. 9.6%; adjOR 2.9; 95% CI 1.5–5.7). Tremor and abnormal FAB score were predicted by an older age at onset while an abnormal FAB score was associated with cramps and family history of neurodegenerative diseases. In conclusion, our data support the notion that newly diagnosed ALS carries a higher than expected risk of extrapyramidal signs and FTD.


Amyotrophic Lateral Sclerosis | 2018

Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortium

Elisabetta Pupillo; Marco Poloni; Elisa Bianchi; Giorgia Giussani; Giancarlo Logroscino; Stefano Zoccolella; Adriano Chiò; Andrea Calvo; Massimo Corbo; Christian Lunetta; Benoît Marin; Douglas Mitchell; Orla Hardiman; James Rooney; Zorica Stevic; Monica Bandettini di Poggio; Massimiliano Filosto; Maria Cotelli; Michele Perini; Nilo Riva; Lucio Tremolizzo; Eugenio Vitelli; Danira Damiani; Ettore Beghi

Abstract Objectives: To assess the association between amyotrophic lateral sclerosis (ALS) and previous traumatic events, age of trauma, and site of injury. Methods: A population-based case-control study was performed in five European countries (Italy, Ireland, France, United Kingdom, Serbia). Newly diagnosed ALS patients and matched controls were interviewed to collect relevant demographic factors and exposures. Key clinical features at diagnosis were collected in ALS patients. Trauma was any accidental event causing an injury. Injuries were dated and classified according to cause, severity, type, site, and complications. All exposures were censored five years before symptoms onset. Risks were computed as odds ratios (OR) with 95% confidence intervals (CI) using univariate and multivariate conditional logistic regression models. Results: Five hundred and seventy-five ALS patients and 1150 controls were interviewed. Disabling traumatic events predominated in the cases (OR 1.54 (95% CI 1.24–1.92)) and maintained significance after adjustment, with a significant gradient. A history of 2 + head injuries was associated with an almost three-fold increased risk of ALS. The risk was almost two-fold when trauma occurred at age 35–54 years. Site of injury was uneventful. Conclusions: Traumatic events leading to functional disability or confined to the head are risk factors for ALS. Traumatic events experienced at age 35–54 years carry the highest risk.


Amyotrophic Lateral Sclerosis | 2018

Amyotrophic lateral sclerosis and food intake

Elisabetta Pupillo; Elisa Bianchi; Adriano Chiò; Federico Casale; Chiara Zecca; Rosanna Tortelli; Ettore Beghi; For Slalom; Parals; and for Slap Groups

Abstract Objective: To verify if specific foods and nutrients could be risk factors or protective factors for amyotrophic lateral sclerosis (ALS). Methods: Patients with newly diagnosed ALS from three Italian administrative regions were included. For each patient, a healthy control, matched for age (±5 years), sex and administrative region of residence, was selected by a general practitioner. Cases and controls were interviewed by a trained investigator who filled a validated and reproducible food-frequency questionnaire. Daily intake of macronutrients, micronutrients, fatty acids, and total energy were estimated using an Italian food composition database. Results: Two hundred and twelve cases and 212 controls were included. A risk reduction was found for coffee and tea (odds ratios (OR) = 0.29, 95% CI 0.14–0.60), whole bread (OR = 0.55, 95% CI 0.31–0.99), raw vegetables (OR = 0.25, 95% CI 0.13–0.52) and citrus fruits (OR = 0.49, 95% CI 0.25–0.97). A risk increase was observed for red meat (OR = 2.96, 95% CI 1.46–5.99) and pork and processed meat (OR = 3.87, 95% CI 1.86–8.07). An increased risk was found for total protein (OR = 2.96, 95% CI 1.08–8.10), animal protein (OR = 2.91, 95% CI 1.33–6.38), sodium (OR = 3.96, 95% CI 1.45–10.84), zinc (OR = 2.78, 95% CI 1.01–7.83) and glutamic acid (OR = 3.63, 95% CI 1.08–12.2). Conclusions: Some foods/nutrients may be risk factors and others protective factors for ALS.


Epilepsia Open , 2 (1) pp. 20-31. (2017) | 2017

EpiNet as a way of involving more physicians and patients in epilepsy research; validation study and accreditation process

Peter S. Bergin; Ettore Beghi; Lynette G. Sadleir; A Brockington; Manjari Tripathi; Mark P. Richardson; Elisa Bianchi; K Srivastava; J Jayabal; B Legros; M Ossemann; Nicole McGrath; A Verrotti; Hj Tan; S Beretta; Richard W. Frith; I Iniesta; E Whitham; J Wanigasinghe; B Ezeala-Adikaibe; P Striano; I Rosemergy; Elizabeth Walker; M Alkhidze; I Rodriguez-Leyva; Ja Ramírez González; Wendyl D'Souza

EpiNet was established to encourage epilepsy research. EpiNet is used for multicenter cohort studies and investigator‐led trials. Physicians must be accredited to recruit patients into trials. Here, we describe the accreditation process for the EpiNet‐First trials.


Archives of Physical Medicine and Rehabilitation | 2017

Prediction of Falls in Subjects Suffering From Parkinson Disease, Multiple Sclerosis, and Stroke

Ettore Beghi; Elisa Gervasoni; Elisabetta Pupillo; Elisa Bianchi; Angelo Montesano; Irene Aprile; Michela Agostini; Marco Rovaris; Davide Cattaneo; Gianluca Iacobone; Johanna Jonsdottir; Alessandra Rodanò; Silvia Romi; Rita Russo; Francesca Tettamanzi; Arianna Cruciani; Isabella Imbimbo; Andrea Polli; Andrea Turolla

OBJECTIVE To compare the risk of falls and fall predictors in patients with Parkinson disease (PD), multiple sclerosis (MS), and stroke using the same study design. DESIGN Multicenter prospective cohort study. SETTING Institutions for physical therapy and rehabilitation. PARTICIPANTS Patients (N=299) with PD (n=94), MS (n=111), and stroke (n=94) seen for rehabilitation. INTERVENTIONS Not applicable. MAIN OUTCOME MEASURES Functional scales were applied to investigate balance, disability, daily performance, self-confidence with balance, and social integration. Patients were followed for 6 months. Telephone interviews were organized at 2, 4, and 6 months to record falls and fall-related injuries. Incidence ratios, Kaplan-Meier survival curves, and Cox proportional hazards models were used. RESULTS Of the 299 patients enrolled, 259 had complete follow-up. One hundred and twenty-two patients (47.1%) fell at least once; 82 (31.7%) were recurrent fallers and 44 (17.0%) suffered injuries; and 16%, 32%, and 40% fell at 2, 4, and 6 months. Risk of falls was associated with disease type (PD, MS, and stroke in decreasing order) and confidence with balance (Activities-specific Balance Confidence [ABC] scale). Recurrent fallers were 7%, 15%, and 24% at 2, 4, and 6 months. The risk of recurrent falls was associated with disease type, high educational level, and ABC score. Injured fallers were 3%, 8%, and 12% at 2, 4, and 6 months. The only predictor of falls with injuries was disease type (PD). CONCLUSIONS PD, MS, and stroke carry a high risk of falls. Other predictors include perceived balance confidence and high educational level.

Collaboration


Dive into the Elisa Bianchi's collaboration.

Top Co-Authors

Avatar

Ettore Beghi

University of Milano-Bicocca

View shared research outputs
Top Co-Authors

Avatar

Giorgia Giussani

Mario Negri Institute for Pharmacological Research

View shared research outputs
Top Co-Authors

Avatar

Elisabetta Pupillo

Mario Negri Institute for Pharmacological Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alessandro Nobili

Mario Negri Institute for Pharmacological Research

View shared research outputs
Top Co-Authors

Avatar

Carlotta Franchi

Mario Negri Institute for Pharmacological Research

View shared research outputs
Top Co-Authors

Avatar

Lucio Tremolizzo

University of Milano-Bicocca

View shared research outputs
Top Co-Authors

Avatar

Valentina Canelli

Mario Negri Institute for Pharmacological Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carlo Ferrarese

University of Milano-Bicocca

View shared research outputs
Researchain Logo
Decentralizing Knowledge